what digital currency to invest in 2021 Top Featured snippets

The turnover of Shanghai, Shenzhen and Beijing exceeded 1 trillion yuan, 55.6 billion yuan more than the previous day. Up to now, the turnover of Shanghai, Shenzhen and Beijing exceeded 1 trillion yuan, 55.6 billion yuan more than the previous day. Among them, the turnover of Shanghai Stock Exchange was 394.6 billion yuan, that of Shenzhen Stock Exchange was 596.3 billion yuan, and that of Beizheng 50 was 11.1 billion yuan.Shenzhen Longgang Yueke Artificial Intelligence Venture Capital Fund was established with a capital contribution of 1 billion yuan. According to Tianyanchao App, recently, Shenzhen Longgang Yueke Artificial Intelligence Venture Capital Fund Partnership (Limited Partnership) was established. The executive partner is Guangdong Yueke Parent Fund Investment Management Co., Ltd., with a capital contribution of 1 billion yuan. The business scope is to engage in equity investment, investment management, asset management and other activities with private equity funds. Shenzhen Longgang District Guide Fund Investment Co., Ltd. and Guangdong Emerging Industry Investment Fund Partnership.Guangxi Energy established a new energy company, and the enterprise search APP showed that Fengyuan (Pinggui District, Hezhou City) New Energy Co., Ltd. was established recently, with Xie Jianheng as the legal representative and a registered capital of 400 million yuan. Its business scope includes: energy storage technical services; Contract energy management; Big data service; Electric vehicle charging infrastructure operation, etc. Enterprise survey shows that the company is wholly owned by Guangxi Energy.

Asia-Pacific Pharmaceuticals: The new specifications of cefmetazole sodium for injection were approved, and Asia-Pacific Pharmaceuticals announced that the company was approved by National Medical Products Administration, and the new specifications of cefmetazole sodium for injection were 0.5g and 2g, which further enriched the product categories on the basis of the original 1g specifications. The annual sales income of this drug in 2023 was 96.3946 million yuan, accounting for 22.92% of the company's operating income. New specifications are helpful to market promotion and competitiveness improvement, but drug production and sales are affected by policies and market environment, and there are uncertainties.Zuo Qiang served as the chairman and secretary of the Party Committee of China Construction No.1 Bureau (Group) Co., Ltd. On the afternoon of December 13th, China Construction No.1 Bureau (Group) Co., Ltd. held a meeting of cadres and workers. China Construction Group announced the decision to supplement the main leaders of China Construction No.1 Bureau (Group) Co., Ltd.: Comrade Zuo Qiang is the chairman and party secretary of China Construction No.1 Bureau (Group) Co., Ltd.Chen Guo, China Securities: The 2025 policy will focus on expanding domestic demand and AI+ in all directions, and the Central Economic Work Conference will be held in Beijing from December 11th to 12th. Chen Guo, chief strategy officer of China Securities, said that the meeting had seven highlights, including clarifying the growth target and fiscal and monetary policy measures, expanding domestic demand in all directions as the top priority of the policy, focusing on "AI+" in science and technology, focusing on implementation of reform measures, paying attention to coping with external shocks in opening up, strengthening the expression of real estate policies, and increasing efforts to improve people's livelihood. Chen Guo said that further RRR cuts and interest rate cuts from the end of 2024 to 2025 are worth looking forward to, and the easing of the liquidity environment has become a market consensus. However, this does not mean that liquidity is rampant, because the growth of money supply in the scale of social financing still continues the requirement of matching the expected target of the overall price level of economic growth. Chen Guo believes that the 2025 policy will focus on expanding domestic demand and AI+ in an all-round way, and the strength and direction of the policy are in line with expectations. With the support of policy expectations and liquidity, it is expected that the market will continue to show the characteristics of volatility. From the perspective of investment strategy, Chen Guo suggested focusing on non-bank finance, real estate chain, consumer electronics, machinery, construction, building materials, steel, social services, catering chain and other sectors. In terms of theme, it is suggested to pay attention to investment opportunities such as "duality" and "two innovations", supply-side optimization, new quality productivity, market value management of state-owned enterprises and CSI A500 index.

The annual evaluation report of the big model in the financial field was released, and the big model of Step Star/Fortune Leap Star performed well. The 6th Shanghai International Forum on Financial Technology was held in Shanghai. At the meeting, Shanghai Artificial Intelligence Laboratory, together with Shanghai University of Finance and Economics and Shanghai Cooper Technology Co., Ltd., released the Report on Evaluation of Large Models in Financial Field (2024), which comprehensively evaluated 20 models from five dimensions: model basic ability, financial security and value alignment ability, financial risk control ability, financial professional cognitive ability and financial business auxiliary expansion ability. The comprehensive scores of Anthropic, Step Star/Fortune Star and Alibaba ranked in the top three. Step-2-16k model of Step Star/Fortune Star got the second comprehensive score, and the multi-modal comprehensive score of Finstep model got the first.Ha Sanlian: Four kinds of drugs are planned to win the bid for national centralized procurement. Ha Sanlian announced that the company and its wholly-owned subsidiary Lanxi Pharmaceutical participated in the tenth batch of national centralized procurement of drugs organized by the state. The company's esmolol hydrochloride injection, pentoxifylline injection, potassium chloride injection, and tandospirone citrate tablets of Lanxi Pharmaceutical intend to win the bid for this centralized procurement. If the subsequent purchase contract is signed and implemented, it will help to expand the sales of related products and improve the market share and brand influence. The prices of the above-mentioned drugs are respectively 1.34 yuan for esmolol hydrochloride injection, 0.59 yuan for pentoxifylline injection, 0.16 yuan for potassium chloride injection and 6.56 yuan for tandospirone citrate tablets.Ministry of Finance of Thailand: It is estimated that the global minimum corporate tax of 15% will be implemented from January 2025.